Add BrightSurf on Google Email

LSU Health study shows promise of NB-UVB phototherapy in hospitalized COVID-19 patients

A randomized, placebo-controlled pilot study found that NB-UVB phototherapy decreased mortality in hospitalized COVID-19 patients with no adverse events reported. The treatment was effective in both vaccinated and unvaccinated patients, with reduced pathologic inflammation and improved intracellular killing of pathogens.

SourceLouisiana State University Health Sciences Center·JournalExperimental Dermatology·TypeRandomized controlled/clinical trial·DateJun 3, 2022

Our cells take their ease in the curves

A UNIGE team discovered that cells in curved tissues swell by 50% before returning to normal, opening avenues for in vitro organ culture. This active phenomenon can be harnessed to control spontaneous growth of organoids and develop new materials with volume increase upon folding.

SourceUniversité de Genève·JournalDevelopmental Cell·TypeNews article·DateMay 13, 2022

Getting sticky with it: Phospholipid found to play a key role in epithelial cell adhesion

Researchers found phosphatidylinositol bisphosphate (PIP2) essential for epithelial cell-cell adhesion and maintaining cellular identity. PIP2 regulates epithelial properties by recruiting Par3 to the plasma membrane, facilitating the formation of adherens junctions and preventing epithelial-mesenchymal transformation.

SourceTokyo University of Science·JournalNature Communications·TypeExperimental study·DateMay 9, 2022

Flexible printable electrical patches for accelerated wound healing

Researchers at Terasaki Institute for Biomedical Innovation have developed a flexible, antibacterial conductive hydrogel-ePatch that accelerates wound healing with minimal side effects. The e-Patch uses silver nanowires and alginate to promote cell proliferation and migration, resulting in faster wound closure and reduced scarring.

SourceTerasaki Institute for Biomedical Innovation·JournalBiomaterials·TypeExperimental study·DateApr 20, 2022

Lab grown, self-sustainable muscle cells repair muscle injury and disease, mouse study shows

Scientists at Johns Hopkins Medicine have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice. The self-renewing stem cells were created by reprogramming laboratory-grown human skin cells, which then differentiated into specific cell types using a nutrient-rich broth.

SourceJohns Hopkins Medicine·JournalCell Stem Cell·DateApr 20, 2022

Better crime scene testing

Researchers at Flinders University have developed more accurate special aerosol fluorescent dye 'marker' to find touch DNA, and found that some people shed more or less DNA on their thumbs. This new study helps understand the difference between high, intermediate and low skin 'shedders', which will aid in crime scene investigation.

SourceFlinders University·JournalForensic Science International Genetics·TypeExperimental study·DateMar 31, 2022

Study of skin biopsies offers potential as new diagnostic marker for Amyotrophic Lateral Sclerosis (ALS)

Researchers have identified a biomarker, TDP-43, detectable in small skin samples of patients with Amyotrophic Lateral Sclerosis (ALS), allowing for potentially easier diagnosis and early detection. The presence of this protein in the skin of ALS patients is associated with an increased number of fibroblasts with disease marks.

SourceUniversitat Autonoma de Barcelona·JournalCells·TypeRandomized controlled/clinical trial·DateMar 24, 2022

Story tips: Beneath the skin, crustacean-inspired cotton, automating clean water, samples in space and capturing furnace emissions

Researchers analyzed skin cell data to identify gene expression patterns responsible for inflammation in atopic dermatitis. Crustacean-inspired cotton was found to control water flow through a special wicking mechanism. Autonomous water treatment systems were also developed to improve energy efficiency and waste reduction.

SourceDOE/Oak Ridge National Laboratory·JournalScience Translational Medicine·TypeExperimental study·DateMar 1, 2022

Patients with rare skin cancer face 40% recurrence rate

Patients with Merkel cell carcinoma face a high risk of recurrence, with 95% of cases occurring within the first three years. The study found that advanced age, male sex, immunosuppression, and known primary lesions are associated with higher recurrence rates, highlighting the need for targeted surveillance efforts.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalJAMA Dermatology·TypeData/statistical analysis·DateFeb 23, 2022

A serendipitous finding lends new insight into how atopic dermatitis develops

Researchers from the University of Pennsylvania and Oak Ridge National Laboratory have identified a cascade of inflammatory signaling that precedes skin ulcers in atopic dermatitis. A mouse model lacking an activator of NF-kB signaling led to the development of skin lesions, shedding light on the early stages of the condition.

SourceUniversity of Pennsylvania·JournalScience Translational Medicine·TypeExperimental study·DateFeb 11, 2022

Immunotherapy with house dust mite extract reduces symptoms of atopic dermatitis

Researchers found sublingual immunotherapy with house dust mite extract to be effective in reducing signs and symptoms of atopic dermatitis. The treatment, administered over 18 months, resulted in significant improvements in pruritus and lesions, with rare side effects.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalJournal of Allergy and Clinical Immunology: In Practice·TypeRandomized controlled/clinical trial·DateFeb 3, 2022

Landing therapeutic genes safely in the human genome

A team of researchers at Harvard's Wyss Institute and ETH Zurich have developed a computational approach to identify genomic safe harbors (GSHs) with high potential for safe insertion of therapeutic genes. The study validated two GSH sites in adoptive T cell therapies and in vivo gene therapies for skin diseases.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalCell Reports Methods·TypeExperimental study·DateJan 24, 2022

Surviving ‘butterfly disease’: long-term success of a new gene and stem-cell therapy for EB verified

A new gene and stem-cell therapy has been proven to be effective in treating Epidermolysis Bullosa (EB), a genetic skin disorder, without any side effects. The treatment, which involves transplanting genetically modified skin cells, has resulted in stable results after five years, with the patient now 13 years old.

SourceUniversity of Münster·JournalNew England Journal of Medicine·DateDec 10, 2021

New cell type in human skin discovered to contribute to inflammatory skin diseases like atopic dermatitis and psoriasis

Researchers identified a new cell type in human skin contributing to AD and psoriasis, highlighting potential therapeutic targets. The study revealed CD14+ type 3 dendritic cells co-producing IL1B and IL23A, essential for PSO pathogenesis.

SourceAgency for Science, Technology and Research (A*STAR), Singapore·JournalJournal of Experimental Medicine·TypeExperimental study·DateSep 17, 2021

Researchers explore promising treatment for MRSA ‘superbug’

A new study from Cornell University has found that the antimicrobial properties of certain stem cell proteins can effectively reduce the viability of methicillin-resistant Staphylococcus aureus (MRSA) in skin wounds. The treatment also stimulates the surrounding skin cells to build up a defense against the bacterial invader.

SourceCornell University·JournalStem Cells Translational Medicine·DateSep 16, 2021

Mutated enzyme weakens connection between brain cells that help control movement

Researchers found a mutation in ELOVL4 enzyme impairs communication between neurons, leading to impaired motor control and coordination. The study provides new insights into the essential role of ELOVL4 in motor function and synaptic plasticity, suggesting potential therapeutic strategies for patients with spinocerebellar ataxia.

SourceMedical College of Georgia at Augusta University·JournalMolecular Neurobiology·DateAug 17, 2021

Skin cells from frontotemporal dementia patients may prove useful in revealing disease mechanisms and in biomarker and drug research

Researchers discovered that skin fibroblasts from FTD patients exhibit pathological RNA foci, p62 protein-containing vesicles, and defective energy metabolism, which could lead to the development of novel biomarkers and treatments. These findings may also be useful in testing drug effects on FTD patients.

SourceUniversity of Eastern Finland·JournalMolecular Neurobiology·DateAug 12, 2021

Multitalented filaments in living cells

Intermediate filaments play a crucial role in maintaining cellular stability, elasticity, and resistance to mechanical stress. The study reveals the physical effects that determine their properties and how they interact with each other in networks.

SourceUniversity of Göttingen·JournalProceedings of the National Academy of Sciences·DateJun 30, 2021

Controlling insulin production with a smartwatch

Researchers at ETH Zurich developed a molecular switch that can be activated by green light from a smartwatch, producing insulin or other substances. The system uses HEK 293 cells and is linked to a gene network, which can be configured to produce specific substances.

SourceETH Zurich·JournalNature Communications·DateJun 7, 2021

Mount Sinai researchers identify mechanisms that are essential for proper skin development

Researchers found that Polycomb repressive complex 1 (PRC1) and Polycomb repressive complex 2 (PRC2) maintain the skin-specific gene expression pattern necessary for proper development of the skin. The study suggests that targeting both complexes may be a more effective form of treatment for certain cancers.

Getting shapes into numbers

A new approach to describing shapes uses a network representation called visibility graph, allowing for comparison and reassembly of complex shapes. The tool, GraVis, accurately quantifies shape parameters such as lobe length and cell area.

SourceMax-Planck-Gesellschaft·JournalNature Communications·DateJan 20, 2021